From: Population-based prevalence of fetal alcohol spectrum disorder in Canada
Students screened in Phase I (n = 2555) | Students eligible for Phase II (n = 817) | Students with deficits in 2+ neuro-developmental domains (n = 323a) | Students selected for case conference review (n = 66b) | Students with suspected FASD (n = 21) | Typically developing control children (n = 83) | Statistical testc | p value | |
---|---|---|---|---|---|---|---|---|
Demographics | ||||||||
Sex (% male) | 48.3 | 55.2 | 58.8 | 50.0 | 52.4 | 59.0 | t = 0.547 | .586 |
Age (years) – mean (SD) | 8.7 (0.9) | 8.6 (0.9) | 8.6 (1.0) | 8.7 (1.0) | 8.9 (0.8) | 8.5 (0.8) | t = 1.859 | .066 |
Range | 6.4–10.8 | 6.7–10.6 | 6.9–10.4 | 6.9–10.3 | 7.6–10.4 | 6.5–10.5 | ||
Ethnicity – n (%) | X = 7.279 | .296 | ||||||
Caucasian | 605 (23.7) | 248 (30.4) | 108 (33.4) | 28 (42.4) | 15 (71.4) | 38 (45.8) | ||
African Canadian | 244 (9.6) | 73 (8.9) | 41 (12.7) | 9 (13.6) | 1 (4.8) | 3 (3.6) | ||
Eastern European | 205 (8.0) | 63 (7.7) | 16 (5.0) | 5 (7.6) | 2 (9.5) | 7 (8.4) | ||
Western European | 394 (15.4) | 124 (15.2) | 50 (15.5) | 11 (16.7) | 3 (14.3) | 16 (19.3) | ||
Chinese/Southeast Asian | 313 (12.3) | 79 (9.7) | 30 (9.3) | 3 (4.6) | 0 (0.0) | 3 (3.6) | ||
South Asian | 353 (13.8) | 95 (11.6) | 31 (9.6) | 4 (6.1) | 0 (0.0) | 8 (9.6) | ||
Other | 437 (17.1) | 135 (16.5) | 47 (14.6) | 6 (9.1) | 0 (0.0) | 8 (9.6) | ||
GROWTH MEASUREMENTS | ||||||||
Height (cm) – mean (SD) | 132.7 (7.9) | 130.2 (8.2) | 131.0 (8.7) | 130.8 (9.1) | 132.8 (7.7) | 133.9 (7.2) | t = 0.633 | .528 |
Height ≤ 10th percentile – n (%) | 278 (10.9) | 202 (24.7) | 70 (21.7) | 18 (27.3) | 5 (23.8) | 2 (2.4) | X = 12.226 | < .001 |
Weight (kg) – mean (SD) | 31.1 (8.0) | 28.7 (7.8) | 29.9 (8.6) | 29.8 (9.2) | 31.3 (9.5) | 32.0 (8.5) | t = 0.346 | .730 |
Weight ≤ 10th percentile – n (%) | 272 (10.7) | 202 (24.7) | 65 (20.1) | 17 (25.8) | 4 (19.1) | 7 (8.4) | X = 1.996 | .158 |
OFC (cm) – mean (SD) | 53.0 (1.7) | 52.31 (1.9) | 52.54 (1.9) | 52.25 (1.9) | 52.5 (2.2) | 53.6 (1.4) | t = 2.942 | .004 |
OFC ≤ 10th percentile – n (%) | 256 (10.0) | 254 (31.1) | 79 (24.5) | 20 (30.3) | 5 (23.8) | 0 (0.0) | X = 20.760 | < .001 |
DYSMORPHOLOGY | ||||||||
Right PFL (cm) – mean (SD) | 2.51 (0.18) | 2.48 (0.19) | 2.50 (0.21) | 2.44 (0.17) | 2.40 (0.15) | 2.51 (0.14) | t = 3.328 | .001 |
Right PFL 2 SD below mean – n (%) | 582 (22.8) | 281 (34.4) | 105 (32.6) | 28 (42.4) | 10 (47.6) | 9 (10.8) | X = 15.180 | < .001 |
Left PFL (cm) – mean (SD) | 2.51 (0.17) | 2.48 (0.18) | 2.50 (0.20) | 2.45 (0.17) | 2.41 (0.16) | 2.51 (0.13) | t = 2.658 | .009 |
Left PFL 2 SD below mean – n (%) | 562 (22.0) | 268 (32.8) | 96 (29.8) | 28 (42.4) | 9 (42.9) | 11 (13.3) | X = 9.456 | .002 |
Inner canthal distance (cm) – mean (SD) | 2.88 (0.26) | 2.82 (0.26) | 2.82 (0.28) | 2.74 (0.25) | 2.84 (0.31) | 2.83 (0.22) | t = 0.253 | .801 |
Inner canthal distance ≤25th percentile – n (%) | 912 (36.3) | 358 (44.6) | 148 (46.7) | 39 (60.9) | 10 (47.6) | 38 (46.3) | X = 4.565 | .335 |
Philtrum length (cm) – mean (SD) | 1.18 (0.24) | 1.19 (0.28) | 1.20 (0.30) | 1.24 (0.40) | 1.17 (0.18) | 1.26 (0.42) | t = 0.895 | .373 |
Philtrum score on lip-philtrum guide – n (%) | X = 1.608 | .658 | ||||||
1 | 175 (6.9) | 47 (5.8) | 15 (4.6) | 2 (3.0) | 0 (0.0) | 1 (1.2) | ||
2 | 907 (35.5) | 238 (29.1) | 90 (27.9) | 15 (22.7) | 5 (23.8) | 30 (36.1) | ||
3 | 1135 (44.4) | 341 (41.7) | 149 (46.1) | 33 (50.0) | 11 (52.4) | 38 (45.8) | ||
4 | 327 (12.8) | 182 (22.3) | 65 (20.1) | 16 (24.2) | 5 (23.8) | 14 (16.9) | ||
5 | 10 (0.4) | 9 (1.1) | 4 (1.2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
Vermillion border score on lip-philtrum guide – n (%) | X = 1.620 | .655 | ||||||
1 | 300 (12.0) | 66 (8.2) | 27 (8.5) | 3 (4.7) | 1 (4.8) | 2 (2.4) | ||
2 | 1135 (45.2) | 323 (40.3) | 134 (42.4) | 21 (32.8) | 9 (42.9) | 35 (42.7) | ||
3 | 926 (36.9) | 315 (39.3) | 124 (39.2) | 31 (48.4) | 7 (33.3) | 36 (43.9) | ||
4 | 143 (5.7) | 93 (11.6) | 29 (9.2) | 9 (14.1) | 4 (19.1) | 9 (11.0) | ||
5 | 5 (0.2) | 5 (0.6) | 2 (0.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) |